Navigation Links
DeepFX(TM) and ActiveFX(TM) Fractional Resurfacing Featured at Annual Meeting of The American Society Of Aesthetic Plastic Surgery
Date:5/8/2008

YOKNEAM, Israel, May 8 /PRNewswire/ -- DeepFX and ActiveFX were featured during this year's annual meeting of The American Society of Aesthetic Plastic Surgery (ASAPS) in San Diego during the Cosmetic Medicine course, chaired by Jeffrey Kenkel, MD of UTSW.

Dr. Kenkel has been using the fractional ActiveFX technology for more than two years, and commented about Lumenis' latest technological advancement. "I'm excited about this new generation of CO2 devices because I can offer my patients a single treatment that provides desired results with manageable downtime," Dr. Kenkel said.

Michael Kulick, MD, of San Francisco showcased DeepFX at the full-day course. Dr. Kulick performed a live DeepFX treatment, answering audience questions regarding pre- and post-treatment protocols, depth of penetration, and optimal settings. He noted that his patient felt little to no discomfort with the treatment, and had less post-operative side effects than other fractional devices that were presented.

Deep FX, the latest in fractional treatment offered by Lumenis Inc., joins the already popular ActiveFX as a powerful way to treat wrinkles, scars, skin tone and texture in a single treatment with minimum downtime.

ActiveFX targets the epidermal and papillary dermal layers of the skin and is ideal for treating conditions that manifest in the upper layers of the skin, including fine lines, dyschromia, and textural irregularities. DeepFX, which was introduced in 2007, targets the deep dermal layers of the skin, and provides exceptional results on deep wrinkles, scars, and peri-oral rhytids.

"The UltraPulse Encore, is the only system with both DeepFX and ActiveFX resurfacing options, providing physicians the most versatile CO2 laser in the industry" commented Dale Koop, Sr. Vice President and head of Lumenis' Strategic Aesthetic Business Unit. "Long known as the 'gold standard' in the industry, the UltraPulse Encore is a shining example of Lumenis' comm
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. UT Southwestern plastic surgeons deploy new carbon dioxide-based fractional laser
3. The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing
4. Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide
5. Keep Father Time From Marching On: New Laser Treatments Offer Gentle and Effective Skin Resurfacing in a Flash
6. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
7. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
8. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
9. Allscripts Featured in Microsoft HealthVault Worldwide Launch
10. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
11. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...me up with a novel idea to boost up the sales of t...are. He has announced a handsome reward of Rs. 100...ate.// "No bird flu case has been registered in t...mport has been banned in the state. We offer a rew...
...vaccinated against diphtheria-tetanus-pertussis. T... causes a red splotch to develop on the area. Thi...that// neither of two common drugs--ibuprofen (Adv...prevent this side effect. A Group Health Cooperati...
... as about 3,000 people in the steel town were affe...irst reported in a small group at a slum// cluster...or its steel plant, Monday. Since then, it has rap...of the town. The high fever is accompanied by vom...
...that stem cell therapy for heart attack may not be...under rigorous conditions//. German researchers ha... improve cardiac function following heart attack. ...ics have had the potential to attract the attentio...
Other Medicine News:Health News:Allergic reaction to DTaP vaccine persists in children 2Health News:Stem Cell Therapy For Heart Attack Found To Be Ineffective 2
(Date:10/6/2008)...with Durezol Dosed Prior to Surgery, TAMPA, Fla.,... a,privately held ophthalmic-focused biopharmaceut...fluprednate ophthalmic emulsion) 0.05% is now,comm... the U.S. Food and,Drug Administration in June 200...d for the treatment of inflammation and pain assoc...
(Date:10/6/2008)...e to severe patients achieved endoscopic,response ...sion at Week 10,in data from a 54-week open-label ...nterology (ACG) Annual Scientific Meeting, ORLAND...d data from a,large, prospective study investigati...with a biologic compound. The data presented at th...
(Date:10/6/2008)...stCall/ -- Dendreon Corporation (Nasdaq:,DNDN) wil... 2008 at 9:00 AM,ET (6:00 AM PT) to review the out...therapy for Prostate AdenoCarcinoma Treatment, als...sipuleucel-T), the Company,s investigational,activ...nced prostate,cancer., Those interested may ac...
(Date:10/3/2008)...s the newest study site, PHILADELPHIA, Oct. 3 /PR... Philadelphia today received a contract to manage ... Children,s Hospital will manage local,participati...County, New,Jersey. The study is funded by the Nat...pate approximately 1,000 families in Burlington,Co...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 1Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 2Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 3Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 4Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 5Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 6Stress may increase a womans risk of developing cervical cancer 12083 1Stress may increase a womans risk of developing cervical cancer 12083 2Daily Stress May Raise Womens Risk of Cervical Cancer 12080 1Daily Stress May Raise Womens Risk of Cervical Cancer 12080 2Daily Stress May Raise Womens Risk of Cervical Cancer 12080 3A map of the worm 3A First detailed anatomical atlas of C elegans for use in the lab 12077 1A map of the worm 3A First detailed anatomical atlas of C elegans for use in the lab 12077 2
...ease Week -, CAMBRIDGE, Mass., May 21, 2007 /PRNew...n of data from a Phase 2 study in which,linaclotid...unction,in patients with constipation- predominant... showed linaclotide was well tolerated with,a low ...t-in-class,compound currently being developed for ...
...rom phase III,clinical trials and further human ph...ress of the European Academy of,Dermatology and Ve...acy and safety profile of alitretinoin as a potent...vere refractory chronic,hand eczema. , Currently, ...nd,Eczema (CHE) refractory or unresponsive to topi...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
Helmer's Horizon Series Plasma Storage Freezers HPF 125-4 incorporate solid performance and value. They feature a microprocessor-based independent temperature controller and alarm/monitor system with
Plasma Blast Chest Freezer -50C - 8098/8091 maintains a -50C (-58F) temperature to rapidly freeze single donor, apheresed, and fresh frozen plasma. Rapid freezing also preserves Factor VIII. Full loa
...for digital histology. It consists of a scanner, a...software modules. At the heart of MIRAX SCAN lies ...s Digital Slides. Any time, from any place. In bri...s on a microscope. The Digital Slide will revoluti...
... incorporates detection of T-wave alternans (TWA) ...nalysis tools. Premier 12 makes a complete 24-hour... provides visualization of the actual TWA, for vis... detects two modes of TWA: the beat-to-beat change...
Medicine Products: